NCT06638307 2026-03-11
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Stemline Therapeutics, Inc.
Phase 1 Recruiting
Stemline Therapeutics, Inc.
MedSIR
University Health Network, Toronto
National Cancer Centre, Singapore
AstraZeneca
Pfizer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Novartis